The Adenosine-Dependent Angiogenic Switch of Macrophages to an M2-Like Phenotype is Independent of Interleukin-4 Receptor Alpha (IL-4Rα) Signaling

Murine macrophages are activated by interferon-gamma (IFN-gamma) and/or Toll-like receptor (TLR) agonists such as bacterial endotoxin (lipopolysaccharide [LPS]) to express an inflammatory (M1) phenotype characterized by the expression of nitric oxide synthase-2 (iNOS) and inflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-12. In contrast, Th2 cytokines IL-4 and IL-13 activate macrophages by inducing the expression of arginase-1 and the anti-inflammatory cytokine IL-10 in an IL-4 receptor-alpha (IL-4R alpha)-dependent manner. Macrophages activated in this way are designated as alternatively activated (M2a) macrophages. We have shown previously that adenosine A(2A) receptor (A(2A)R) agonists act synergistically with TLR2, TLR4, TLR7, and TLR9 agonists to switch macrophages into an M2-like phenotype that we have termed M2d. Adenosine signaling suppresses the TLR-dependent expression of TNF-alpha, IL-12, IFN-gamma, and several other inflammatory cytokines by macrophages and induces the expression of vascular endothelial growth factor (VEGF) and IL-10. We show here using mice lacking a functional IL-4R alpha gene (IL-4R alpha(-/-) mice) that this adenosine-mediated switch does not require IL-4R alpha-dependent signaling. M2d macrophages express high levels of VEGF, IL-10, and iNOS, low levels of TNF-alpha and IL-12, and mildly elevated levels of arginase-1. In contrast, M2d macrophages do not express Ym1, Fizz1 (RELM-alpha), or CD206 at levels greater than those induced by LPS, and dectin-1 expression is suppressed. The use of these markers in vivo to identify M2 macrophages thus provides an incomplete picture of macrophage functional status and should be viewed with caution.